1 2 aim

Update on Duchenne UK’s survey and workshop to discuss the use of re-purposed or off label medicines

Last month, Duchenne UK hosted a workshop to discuss the use of re-purposed or off label medicines. We conducted a survey among the community and would like to thank everyone who took the time to participate in the survey. Duchenne UK is currently co-funding a clinical trial looking at Tamoxifen as a treatment for DMD. We will be working with clinicians and regulatory consultants to look at ways of progressing the development of other repurposed medicines.

Download and read the full report here. Click here to view the Survey Results and Analysis.

World Duchenne
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.